1,024
Views
3
CrossRef citations to date
0
Altmetric
MIATA Compliant Research Paper

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts

, , , , , , , , , , , , & show all
Article: e1412030 | Received 20 Jun 2017, Accepted 26 Nov 2017, Published online: 17 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now

Articles from other publishers (2)

Myriam Ben Khelil, Luc Aeberli, Marie Perchaud, Raphael Genolet, Syrine Abdeljaoued, Christophe Borg, Delphine Binda, Alexandre Harari, Camilla Jandus, Georges Muller & Romain Loyon. (2022) A new workflow combining magnetic cell separation and impedance-based cell dispensing for gentle, simple and reliable cloning of specific CD8+ T cells. SLAS Technology 27:2, pages 130-134.
Crossref
Patricia Mercier-LetondalChrystel MartonMarina DeschampsChristophe FerrandCharline VauchyClément ChenutAurélie BaguetOlivier AdotéviChristophe BorgJeanne GalaineYann Godet. (2018) Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy. Human Gene Therapy 29:10, pages 1202-1212.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.